Kizoo Portfolio Company Revel Pharmaceuticals Announces $8.4M Seed To Develop Repairing-Based Approaches To Reversing Aging

Mar 17, 2022•over 3 years ago

Amount Raised

$8.4 Million

Round Type

seed

Madrid

Description

Revel Pharmaceuticals, a longevity therapeutics company developing enzymes to repair damage from aging, announced today that it has raised $8.4M in Seed financing. The oversubscribed round was led by Kizoo Technology Capital, a leading early-stage investor in breakthrough rejuvenation technologies, and Starbloom Capital with participation from Tubus LLC. The funds will support Revel as it advances its repair-based enzyme therapy pipeline towards the clinic.

Company Information

Company

Revel

Location

Madrid, Community Of Madrid, Spain

About

REVEL offers an all-inclusive, flexible car subscription service in Spain, that offsets your emissions while you drive and helps you transition to an electrical vehicle. At REVEL our mission is making car ownership more convenient, affordable, and sustainable for everyone. With REVEL you can easily subscribe to a car through a 100% digital process, receive it at your doorstep in a few days, keep it as long as you want, and enjoy driving in the meantime while we compensate all the CO2 of your car, so every kilometer driven in a REVEL has a positive environmental impact in the planet.

Kizoo Portfolio Company Revel Pharmaceuticals Announces $8.4M Seed To Develop Repairing-Based Approaches To Reversing Aging

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information